| Literature DB >> 29246441 |
Katharina Essig1, Desheng Hu2, Joao C Guimaraes3, Dominik Alterauge1, Stephanie Edelmann4, Timsse Raj1, Jan Kranich1, Gesine Behrens1, Alexander Heiseke1, Stefan Floess5, Juliane Klein1, Andreas Maiser6, Susan Marschall7, Martin Hrabĕ de Angelis7, Heinrich Leonhardt6, Cornelis F Calkhoven8, Elfriede Noessner9, Thomas Brocker1, Jochen Huehn5, Anne B Krug1, Mihaela Zavolan3, Dirk Baumjohann1, Vigo Heissmeyer10.
Abstract
Roquin proteins preclude spontaneous T cell activation and aberrant differentiation of T follicular helper (Tfh) or T helper 17 (Th17) cells. Here we showed that deletion of Roquin-encoding alleles specifically in regulatory T (Treg) cells also caused the activation of conventional T cells. Roquin-deficient Treg cells downregulated CD25, acquired a follicular Treg (Tfr) cell phenotype, and suppressed germinal center reactions but could not protect from colitis. Roquin inhibited the PI3K-mTOR signaling pathway by upregulation of Pten through interfering with miR-17∼92 binding to an overlapping cis-element in the Pten 3' UTR, and downregulated the Foxo1-specific E3 ubiquitin ligase Itch. Loss of Roquin enhanced Akt-mTOR signaling and protein synthesis, whereas inhibition of PI3K or mTOR in Roquin-deficient T cells corrected enhanced Tfh and Th17 or reduced iTreg cell differentiation. Thereby, Roquin-mediated control of PI3K-mTOR signaling prevents autoimmunity by restraining activation and differentiation of conventional T cells and specialization of Treg cells.Entities:
Keywords: Akt mTOR; CD25; Foxo1; Itch; Pten; RNA-binding proteins; Roquin; T cell differentiation; Tfh; Tfr
Mesh:
Substances:
Year: 2017 PMID: 29246441 DOI: 10.1016/j.immuni.2017.11.008
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745